
Microbot Medical, Inc. Common Stock
MBOT
MBOT: Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
moreShow MBOT Financials
Recent trades of MBOT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MBOT's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Device for automatically inserting and manipulating a medical tool into and within a bodily lumen Apr. 05, 2022
-
Patent Title: Modular robotic system for driving movement of surgical tools Feb. 08, 2022
-
Patent Title: Device for automatically inserting and manipulating a medical tool into and within a bodily lumen Jan. 04, 2022
-
Patent Title: Device for prevention of shunt stenosis Jan. 26, 2021
Federal grants, loans, and purchases
Followers on MBOT's company Twitter account
Number of mentions of MBOT in WallStreetBets Daily Discussion
Recent insights relating to MBOT
Recent picks made for MBOT stock on CNBC
ETFs with the largest estimated holdings in MBOT
Flights by private jets registered to MBOT